SCHEMBL3385937

SCHEMBL3385937

O=C(NC/C=C/c1cccc([S+]([O-])CC2CCCC2)c1)C(F)(F)F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
HDAC6 Q9UBN7 3/20 0.36
MLYCD O95822 1/20 0.32
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
TLR4 O00206 1/20 0.31
TLR2 O60603 1/20 0.31
ATM Q13315 1/20 0.31
MTNR1A P48039 1/20 0.30
MTNR1B P49286 1/20 0.30
NPC1 O15118 1/20 0.30
HDAC3 O15379 1/20 0.30
HDAC4 P56524 1/20 0.30
HDAC1 Q13547 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
MAPT P10636 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3385943 1.00 ALDH1A1 (0.37) ALDH1A1HDAC6MLYCDMEN1KMT2A
SCHEMBL3389935 0.99 ALDH1A1 (0.39) ALDH1A1HDAC6MLYCDMEN1KMT2A
SCHEMBL3389932 0.99 ALDH1A1 (0.39) ALDH1A1HDAC6MLYCDMEN1KMT2A
SCHEMBL13400302 0.81 EPHX1 (0.34) ALDH1A1TLR4TLR2MTNR1AMTNR1B
SCHEMBL3388475 0.79 ALDH1A1 (0.33) ALDH1A1
SCHEMBL3388480 0.79 ALDH1A1 (0.33) ALDH1A1
SCHEMBL3387265 0.78 TLR4 (0.35) ALDH1A1TLR4TLR2
SCHEMBL3387259 0.78 TLR4 (0.35) ALDH1A1TLR4TLR2
SCHEMBL13400308 0.77 AR (0.38) ALDH1A1HDAC6MLYCD
SCHEMBL3388478 0.77 TLR4 (0.37) ALDH1A1TLR4TLR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100093865-A1 SULPHUR-LINKED COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS ACUCELA, INC. (US) 2010-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100093865-A1 SULPHUR-LINKED COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS ALDH1A2, MPST, CLN6 ALDH1A1 314/4885HDAC6 250/4885MLYCD 1007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.